Goldman said a successful vaccine may rattle markets, supporting steeper yield curves, traditional cyclicals and banks and challenging the leadership of tech stocks. The firm's strategists see options trades as a way to play the theme. The probability of a vaccine by end-November is underpriced. And by then we'll know the election result and how the start of the school year impacted the virus's spread.